Earnings History Data for Acer Therapeutics (ACER) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Acer Therapeutics

Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics, Inc., is based in Cambridge, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-08-2023	AH		ACER	Acer Therapeutics	17.00	-0.23	-0.26	0.00	Acer Therapeutics GAAP EPS of -$0.33 [8/14/2023 5:02 PM]	0.75	-0.18 (-18.92%)	0.87	-0.06 (-5.95%)	0.65 - 4.56	108,619	120,000	1,337
Acer Therapeutics GAAP EPS of -$0.33 [8/14/2023 5:02 PM]
27-03-2023	AH		ACER	Acer Therapeutics	16.00	-0.32	-0.35	0.00	Acer Therapeutics GAAP EPS of -$0.54 misses by $0.17 [3/27/2023 5:02 PM]	0.75	-0.01 (-1.06%)	0.76	0.0 (0.26%)	0.65 - 4.56	234,279	1,090,000	328
Acer Therapeutics GAAP EPS of -$0.54 misses by $0.17 [3/27/2023 5:02 PM]
14-11-2022	PM	4:00 PM ET (Nov 14)	ACER	Acer Therapeutics	19.00	-0.31	-0.76	0.00	Acer Therapeutics GAAP EPS of -$0.31 beats by $0.37 [11/15/2022 4:00 AM]	1.19	-0.01 (-0.83%)	0.0	0.0 (0.00%)	1.11 - 3.77	136,523	70,000	0
Acer Therapeutics GAAP EPS of -$0.31 beats by $0.37 [11/15/2022 4:00 AM] Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update [Nov-14-22 05:08PM]
15-08-2022	AH		ACER	Acer Therapeutics	23.00	-0.48	-0.58	0.00	Acer Therapeutics GAAP EPS of -$0.17 beats by $0.42 [8/15/2022 5:26 PM]	1.50	-0.02 (-1.32%)	1.50	-0.02 (-1.32%)	1.16 - 3.77	57,272	120,000	12,329
Acer Therapeutics GAAP EPS of -$0.17 beats by $0.42 [8/15/2022 5:26 PM] Acer Therapeutics Reports Q2 2022 Financial Results and Provides Corporate Update [Aug-15-22 04:00PM] Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease [Aug-12-22 08:30AM]
02-03-2022	AH		ACER	Acer Therapeutics Inc.	35.00	-0.31	-0.08	0.00	Acer Therapeutics GAAP EPS of -$0.31 misses by $0.30, revenue of $0.36M misses by $2.97M [3/2/2022 5:26 PM]	2.49	0.05 (2.05%)	2.43	-0.01 (-0.41%)	1.68 - 5.39	5,391	80,000	150
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update [Mar-02-22 05:18PM]
19-11-2021	AH		ACER	Opexa Therapeutics	34.00	-0.23	-0.28	0.00	Acer Therapeutics EPS beats by $0.05 [11/19/2021 5:14 PM]	2.24	-0.10 (-4.27%)	2.24	-0.10 (-4.27%)	2.15 - 5.39	136,446	70,000	8,784
Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update [Nov-19-21 05:00PM] 5 Stocks To Watch For November 22, 2021 [Nov-22-21 03:43AM]
10-08-2021	AH		ACER	Opexa Therapeutics, Inc.	37.00	-0.23	-0.36	0.00	Acer Therapeutics EPS beats by $0.13 [8/10/2021 5:17 PM]	2.44	-0.10 (-3.94%)	2.50	-0.04 (-1.57%)	2.15 - 5.55	125,596	1,040,000	970
Acer Therapeutics EPS beats by $0.13 [8/10/2021 5:17 PM] Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update [Aug-10-21 04:05PM] Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders [Aug-09-21 08:30AM] RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders [Aug-09-21 01:30AM] Opexa Therapeutics, Inc. (ACER) Reports Q2 Loss, Misses Revenue Estimates [Aug-10-21 06:45PM]
17-05-2021	AH		ACER	Opexa Therapeutics, Inc.	36.00	-0.11	-0.41	0.00	Acer Therapeutics EPS beats by $0.30, beats on revenue [5/17/2021 4:28 PM]	2.72	0.04 (1.49%)	2.85	0.17 (6.34%)	2.15 - 5.84	134,105	70,000	1,406
Acer Therapeutics EPS beats by $0.30, beats on revenue [5/17/2021 4:28 PM] Acer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update [May-17-21 04:01PM]
01-03-2021	AH	4:05 PM ET (Mar 1)	ACER	Opexa Therapeutics, Inc.	39.00	-0.50	-0.43	0.00	Acer Therapeutics EPS misses by $0.09 [3/1/2021 4:49 PM]	3.20	-0.04 (-1.38%)	3.32	0.07 (2.15%)	1.08 - 5.84	167,446	199,456	9,017
Acer Therapeutics EPS misses by $0.09 [3/1/2021 4:49 PM] Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-01-21 04:05PM] Acer Therapeutics to Participate in March Virtual Investor Conferences [Mar-01-21 08:30AM]
10-11-2020	AH		ACER	Opexa Therapeutics, Inc.	31.00	-0.51	-0.44	0.00	Acer Therapeutics EPS misses by $0.05 [11/10/2020 4:39 PM]	2.63	-0.06 (-2.23%)	2.80	0.11 (4.09%)	1.08 - 7.25	33,443	60,337	104

10-11-2020	AH		ACER	Acer Therapeutics Inc.	31.69	-0.51	-0.44	-0.52	Acer Therapeutics EPS misses by $0.05 [11/10/2020 4:39 PM]	2.63	-0.06 (-2.23%)	2.80	0.11 (4.09%)	1.08 - 7.25	33,443	60,337	104